4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0001193125-26-009272
Chief Executive Officer sold 11,582 shares
- Chief Executive Officer acquired 81,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Davidson Michael H. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-07 | Sale : show line 1 in the form 10b5-1 | −11,582 | 378,859 | D |
| 2026-01-07 | Grant or award : show line 2 in the form 10b5-1 | +81,000 | 459,859 | D |
| Open-market sales · 11,582 sh | ||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-07 | Grant or award : show line 3 in the form 10b5-1 Option (right to buy) | +364,000 | 364,000 | D |
Loading xslF345X05/ownership.xml…